VirtualScopics Schedules Third Quarter 2008 Earnings An...(the Company undertakes no obligation to ...),Health
Navigation Links
VirtualScopics Schedules Third Quarter 2008 Earnings Announcement
Date:10/28/2008
the Company undertakes no obligation to update such forward-looking statements.
CONTACT:
Molly Henderson
Chief Business and Financial Officer
500 Linden Oaks
Rochester, New York 14625
(585)249.6231
'/>"/>
| SOURCE VirtualScopics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. VirtualScopics Reports Second Quarter 2008 Results
2. VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting
3. VirtualScopics Backlog Exceeds a Record $20 Million
4. VirtualScopics Announces $4.35 Million Private Placement
5. Varian Medical Systems Schedules Fiscal Year End Review in New York
6. Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results
7. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Second Quarter 2008 Results
8. The Ensign Group Schedules 2008 Second Quarter Earnings Call for Thursday, August 7, 2008
9. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
10. AMICAS Schedules Second Quarter Earnings Call
11. Mylan Schedules Financial Results Conference Call and Live Webcast for the Second Quarter Fiscal 2008
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Fastrack Announces Major Expansion 2Health News:Fastrack Announces Major Expansion 3Health News:pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W) 2Health News:Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 2Health News:University of Utah Announces New Studies on the Benefits of Treadmill Desks 2Health News:University of Utah Announces New Studies on the Benefits of Treadmill Desks 3Health News:Nonprofit Partners With PR Company and Gains International Attention 2
[0] Fastrack Announces Major Expansion[0] pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W)[0] Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction[0] University of Utah Announces New Studies on the Benefits of Treadmill Desks[0] Nonprofit Partners With PR Company and Gains International Attention
Other Medicine News:Health News:New Guidelines Tackle Treatment of Resistant Hypertension 2Health News:New Guidelines Tackle Treatment of Resistant Hypertension 3Health News:Mother's Day Gifts from Deerfield Spa Give Moms What They Love Most ... Photographs and Memories 2Health News:Blood pressure enzyme can have tumor-sensing role 2Health News:CAS' New SciFinder(R) Enhances the Research Experience Via the Web 2Health News:Schizophrenia: Diagnosis Is Not Destiny - Conference 2Health News:Robot-assisted minimally-invasive CABG surgery 2
New Guidelines Tackle Treatment of Resistant HypertensionMother's Day Gifts from Deerfield Spa Give Moms What They Love Most ... Photographs and MemoriesBlood pressure enzyme can have tumor-sensing roleCAS' New SciFinder(R) Enhances the Research Experience Via the WebSchizophrenia: Diagnosis Is Not Destiny - ConferenceRobot-assisted minimally-invasive CABG surgery
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6HCA Reports Second Quarter 2009 Results 53037 1HCA Reports Second Quarter 2009 Results 53037 2HCA Reports Second Quarter 2009 Results 53037 3HCA Reports Second Quarter 2009 Results 53037 4HCA Reports Second Quarter 2009 Results 53037 5HCA Reports Second Quarter 2009 Results 53037 6HCA Reports Second Quarter 2009 Results 53037 7HCA Reports Second Quarter 2009 Results 53037 8HCA Reports Second Quarter 2009 Results 53037 9HCA Reports Second Quarter 2009 Results 53037 10HCA Reports Second Quarter 2009 Results 53037 11HCA Reports Second Quarter 2009 Results 53037 12HCA Reports Second Quarter 2009 Results 53037 13HCA Reports Second Quarter 2009 Results 53037 14Sanofi aventis Announces Second Quarter 2009 Results 13244 1Sanofi aventis Announces Second Quarter 2009 Results 13244 2Sanofi aventis Announces Second Quarter 2009 Results 13244 3Sanofi aventis Announces Second Quarter 2009 Results 13244 4Sanofi aventis Announces Second Quarter 2009 Results 13244 5Sanofi aventis Announces Second Quarter 2009 Results 13244 6Sanofi aventis Announces Second Quarter 2009 Results 13244 7Sanofi aventis Announces Second Quarter 2009 Results 13244 8Sanofi aventis Announces Second Quarter 2009 Results 13244 9Sanofi aventis Announces Second Quarter 2009 Results 13244 10Sanofi aventis Announces Second Quarter 2009 Results 13244 11Sanofi aventis Announces Second Quarter 2009 Results 13244 12Sanofi aventis Announces Second Quarter 2009 Results 13244 13Sanofi aventis Announces Second Quarter 2009 Results 13244 14Sanofi aventis Announces Second Quarter 2009 Results 13244 15Sanofi aventis Announces Second Quarter 2009 Results 13244 16Sanofi aventis Announces Second Quarter 2009 Results 13244 17Sanofi aventis Announces Second Quarter 2009 Results 13244 18Sanofi aventis Announces Second Quarter 2009 Results 13244 19Sanofi aventis Announces Second Quarter 2009 Results 13244 20Sanofi aventis Announces Second Quarter 2009 Results 13244 21Sanofi aventis Announces Second Quarter 2009 Results 13244 22Sanofi aventis Announces Second Quarter 2009 Results 13244 23Sanofi aventis Announces Second Quarter 2009 Results 13244 24Sanofi aventis Announces Second Quarter 2009 Results 13244 25Sanofi aventis Announces Second Quarter 2009 Results 13244 26Sanofi aventis Announces Second Quarter 2009 Results 13244 27GCP Helpdesk 3A Launch Announcement of gcphelpdesk com 53032 1
[0] Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine[0] Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix[0] Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |